Q87.19
Other congenital malformation syndromes predominantly associated with short stature
Clinical Classification Guidelines
Inclusion Terms
- Aarskog syndrome
- Cockayne syndrome
- De Lange syndrome
- Dubowitz syndrome
- Noonan syndrome
- Robinow-Silverman-Smith syndrome
- Russell-Silver syndrome
- Seckel syndrome
Medical Intelligence & Overview
ICD-10 code Q87.19 refers to various congenital malformation syndromes that are primarily characterized by short stature. These syndromes are rare genetic conditions marked by distinct physical features and developmental challenges. Recognizing these syndromes can be crucial for early diagnosis and management, although specific medical interventions should always be guided by healthcare professionals. Common syndromes associated with this code include Aarskog syndrome, Cockayne syndrome, De Lange syndrome, Dubowitz syndrome, Noonan syndrome, Robinow-Silverman-Smith syndrome, Russell-Silver syndrome, and Seckel syndrome.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents or occurring as new mutations Chromosomal abnormalities affecting growth and development Disruptions in specific genes responsible for physical development Environmental factors generally not primary causes, but may contribute to developmental issues in certain syndromes
Key Symptoms: Significant short stature compared to peers Distinct facial features such as a prominent forehead, a thin upper lip, or broad nasal bridge Delayed growth milestones in childhood Developmental delays or intellectual disabilities Musculoskeletal abnormalities, including joint hyperflexibility or skeletal anomalies Organ or tissue abnormalities depending on the specific syndrome Additional features specific to each syndrome, for example: Noonan syndrome: heart defects, chest deformities Russell-Silver syndrome: asymmetry, low birth weight De Lange syndrome: limb abnormalities, finger deformities
Diagnostic & Treatment
Diagnosis Path: Diagnosing these syndromes often involves a combination of physical examinations, family history assessment, and genetic testing. Specific features observed in newborns or children can prompt targeted genetic analyses, such as chromosome studies or gene sequencing, to confirm the diagnosis. Imaging techniques like X-rays may be used to assess skeletal anomalies. Early diagnosis is vital for managing associated health issues and providing supportive care.
Treatment Protocols: Growth hormone therapy to promote height in certain conditions Educational support and developmental interventions for cognitive delays Surgical procedures for structural anomalies if necessary Monitoring and management of cardiac, orthopedic, or other organ-specific issues Regular follow-up with multidisciplinary teams including genetics, cardiology, orthopedics, and developmental specialists
Clinical Advice & FAQs
Billing Guidance
Is Q87.19 a billable ICD-10 code?
Yes, Q87.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q87.19?
Clinical documentation must specify the nature of Other congenital malformation syndromes predominantly associated with short stature and any associated comorbidities for accurate reporting.
Cite this Clinical Reference